• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Board #153 - Research Abstract The Creation of a Simulator Value Index Tool by Connected Consensus (Submission #8590).
Conclusion: The product from this work (SVI Worksheet tool) can be applied aid the simulator purchase process across countries, institutions, and stakeholder. We are hopeful that simulator purchase processes might include the SVI Worksheet with the intention to maintain alignment with educational goals, while still accounting for other factors considered at the institutional level. At the same time, common measures might facilitate future communication across academic medical institutions and simulator industry. More evaluation is required following broad-scaled implementation. References: 1. Britt RC, Novosel TJ, Britt LD...
Source: Simulation in Healthcare: The Journal of the Society for Simulation in Healthcare - December 1, 2014 Category: Medical Equipment Tags: Abstracts: 2ND PLACE AWARD WINNER: PDF Only Source Type: research

Cardiologs wins FDA 510(k) for ECG analysis platform
Cardiologs Technologies said today it won FDA 510(k) clearance for its Cardiologs ECG analysis platform designed to aid in the screening for atrial fibrillation and other arrhythmias. The platform is a cloud-based cardiac monitoring and analysis web service which uses artificial intelligence to analyze long-term ambulatory ECG monitoring recordings, the Paris-based company said. The system already has CE Mark approval in the European Union, the company added. “It is intuitive that screening for AFib and subsequent anticoagulant treatment should reduce the stroke burden, which is the basis of guideline recommendations...
Source: Mass Device - July 6, 2017 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Cardiovascular Food & Drug Administration (FDA) Regulatory/Compliance cardiologstechnologies Source Type: news

HRS: Ear Clip Uses Neurostimulation to Effectively Reduce AFib Burden
A trial evaluating Parasym’s neurostimulation technology shows the ear-clip like device can help reduce the atrial fibrillation burden. The results were presented at the Heart Rhythm Society’s 40th Annual Scientific Sessions held in San Francisco. The TREAT AF trial is a sham-controlled, double-blind, randomized clinical trial designed to examine the effect of low-level transcutaneous electrical stimulation of the auricular branch of the vagus nerve at the tragus (LLTS) on AFib burden over a six-month period. LLTS was delivered using an ear clip attached to either tragus (active; n=26) o...
Source: MDDI - May 9, 2019 Category: Medical Devices Authors: MDDI Staff Tags: Cardiovascular Source Type: news